Lv6
2088 积分 2024-04-22 加入
Lessons learned in linking PROTACs from discovery to the clinic
14天前
已完结
Computational methods and key considerations for in silico design of proteolysis targeting chimera (PROTACs)
17天前
已完结
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
18天前
已完结
Trends in kinase drug discovery: targets, indications and inhibitor design
18天前
已完结
A quantitative analysis of kinase inhibitor selectivity
18天前
已完结
Peptide-based PROTACs: Current Challenges and FuturePerspectives
1个月前
已完结
Protein degraders enter the clinic — a new approach to cancer therapy
1个月前
已完结
SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies
2个月前
已完结
Small-molecule displacement of a cryptic degron causes conditional protein degradation
2个月前
已完结
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2个月前
已完结
皖公网安备34019202002308
